2016
DOI: 10.3349/ymj.2016.57.1.64
|View full text |Cite
|
Sign up to set email alerts
|

Left Ventricular Filling Pressure as Assessed by the E/e' Ratio Is a Determinant of Atrial Fibrillation Recurrence after Cardioversion

Abstract: PurposeLeft ventricular (LV) filling pressure affects atrial fibrillation (AF) recurrence. We investigated the relationship between diastolic dysfunction and AF recurrence after cardioversion, and whether LV filling pressure was predictive of AF recurrence.Materials and MethodsSixty-six patients (mean 58±12 years) with newly diagnosed persistent AF were retrospectively enrolled. We excluded patients with left atrial (LA) diameters larger than 50 mm, thereby isolating the effect of LV filling pressure. We evalu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
12
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 23 publications
2
12
0
Order By: Relevance
“…216 Indicators of an underlying HFpEF (increases in LA chamber size, decreases in LA conduit function, abnormal LV diastolic filling dynamics or biomarkers of systemic inflammation) identify those individuals who are unlikely to maintain sinus rhythm, whether the AF is treated electrically or pharmacologically. [217][218][219][220][221][222][223] Furthermore, the intensive post-procedural use of membrane-active anti-arrhythmic drugs carries its own risk for proarrhythmia and worsening HF, particularly in patients with AF and an underlying ventricular myopathy (i.e. HFpEF).…”
Section: Pharmacological and Procedural Rhythm Controlmentioning
confidence: 99%
See 1 more Smart Citation
“…216 Indicators of an underlying HFpEF (increases in LA chamber size, decreases in LA conduit function, abnormal LV diastolic filling dynamics or biomarkers of systemic inflammation) identify those individuals who are unlikely to maintain sinus rhythm, whether the AF is treated electrically or pharmacologically. [217][218][219][220][221][222][223] Furthermore, the intensive post-procedural use of membrane-active anti-arrhythmic drugs carries its own risk for proarrhythmia and worsening HF, particularly in patients with AF and an underlying ventricular myopathy (i.e. HFpEF).…”
Section: Pharmacological and Procedural Rhythm Controlmentioning
confidence: 99%
“…However, both obesity and type 2 diabetes diminish the likelihood that sinus rhythm will be maintained following electrical cardioversion, because greater epicardial adipose tissue volumes and the resulting inflammation are important determinants of AF recurrence . Indicators of an underlying HFpEF (increases in LA chamber size, decreases in LA conduit function, abnormal LV diastolic filling dynamics or biomarkers of systemic inflammation) identify those individuals who are unlikely to maintain sinus rhythm, whether the AF is treated electrically or pharmacologically . Furthermore, the intensive post‐procedural use of membrane‐active anti‐arrhythmic drugs carries its own risk for proarrhythmia and worsening HF, particularly in patients with AF and an underlying ventricular myopathy (i.e.…”
Section: Therapeutic Challenges In Patients With a Metabolic Disordermentioning
confidence: 99%
“…In one study that included 127 patients with left atrial dilatation, septal E/e' >11 predicted recurrence of AF after cardioversion (p = 0.001) in multivariate analysis, after adjusting for duration of arrhythmia before cardioversion (p = 0.04) and systolic pulmonary arterial pressure (p = 0.001) [66] . In another study that included 66 patients with AF and left atrial diameter <50 mm, septal E/e' was independently associated with recurrence of arrhythmia after cardioversion (p = 0.017), after adjusting for left atrial volume (p = 0.04) [67] .…”
Section: Relevance Of E/e' In Predicting Recurrence Of Af After Cathementioning
confidence: 95%
“…Clinical, echocardiographic, and biochemical parameters are currently sought to help assess the prognosis of SR maintenance after DCCV [5][6][7]. The echocardiographic parameters most frequently mentioned as prognostic factors for SR maintenance are those assessing the structural remodeling of the left atrium, including the LA antero-posterior diameter (LAAP) and the LA volume index (LAVI); those assessing mechanical remodeling, such as the LA emptying fraction (LAEF) assessed during SR; and those assessing the left ventricular filling pressure (LVFP) [8][9][10][11][12][13][14][15][16][17][18][19]. Most studies have focused on the echocardiographic parameters measured during SR, following a successful DCCV.…”
Section: Introductionmentioning
confidence: 99%